FDA inspection
Ningbo Renjian Pharmaceutical Group Co., Ltd: FDA inspection ending May 17, 2024
FDA inspection 1242486 · No Action Indicated (NAI) · Ningbo
Key facts
| Inspection ID | 1242486 |
|---|---|
| Firm | Ningbo Renjian Pharmaceutical Group Co., Ltd |
| FEI number | 3004160744 |
| Address | 555 Changchi Road, Cixi |
| City | Ningbo |
| Country | China |
| Fiscal year | 2024 |
| Inspection end date | May 17, 2024 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data